epithelial–mesenchymal transition epithelial–mesenchymal transition the epithelial–mesenchymal transition (emt) is a process by which epithelial cells lose their cell polarity and cell–cell adhesion, and gain migratory and invasive properties to become mesenchymal stem cells; these are multipotent stromal cells that can differentiate into a variety of cell types. emt is essential for numerous developmental processes including mesoderm formation and neural tube formation. emt has also been shown to occur in wound healing, in organ fibrosis and in the initiation of metastasis in cancer progression. epithelial-mesenchymal transitiondiagram showing the epithelial-mesenchymal transitiondetailsprecursorendodermidentifiersmeshd058750anatomical terminology introduction human embryo—length, 2 mm. dorsal view, with the amnion laid open. x 30. epithelial–mesenchymal transition was first recognized as a feature of embryogenesis by betty hay in the 1980s. emt, and its reverse process, met (mesenchymal-epithelial transition) are critical for development of many tissues and organs in the developing embryo, and numerous embryonic events such as gastrulation, neural crest formation, heart valve formation, secondary palate development, and myogenesis. epithelial and mesenchymal cells differ in phenotype as well as function, though both share inherent plasticity. epithelial cells are closely connected to each other by tight junctions, gap junctions and adherens junctions, have an apico-basal polarity, polarization of the actin cytoskeleton and are bound by a basal lamina at their basal surface. mesenchymal cells, on the other hand, lack this polarization, have a spindle-shaped morphology and interact with each other only through focal points. epithelial cells express high levels of e-cadherin, whereas mesenchymal cells express those of n-cadherin, fibronectin and vimentin. thus, emt entails profound morphological and phenotypic changes to a cell. based on the biological context, emt has been categorized into 3 types: developmental (type i), fibrosis and wound healing (type ii), and cancer (type iii). inducers key inducers of the epithelial to mesenchymal transition process. epithelial to mesenchymal cell transition – loss of cell adhesion leads to constriction and extrusion of newly mesenchymal cell. loss of e-cadherin is considered to be a fundamental event in emt. many transcription factors (tfs) that can repress e-cadherin directly or indirectly can be considered as emt-tf (emt inducing tfs). snai1/snail 1, snai2/snail 2 (also known as slug), zeb1, zeb2, tcf3 and klf8 (kruppel-like factor 8) can bind to the e-cadherin promoter and repress its transcription, whereas factors such as twist, goosecoid, tcf4 (also known as e2.2), homeobox protein six1 and foxc2 (fork-head box protein c2) repress e-cadherin indirectly. snail and zeb factors bind to e-box consensus sequences on the promoter region, while klf8 binds to promoter through gt boxes. these emt-tfs not only directly repress e-cadherin, but also repress transcriptionally other junctional proteins, including claudins and desmosomes, thus facilitating emt. on the other hand, transcription factors such as grainyhead-like protein 2 homologue (grhl2), and ets-related transcription factors elf3 and elf5 are downregulated during emt and are found to actively drive met when overexpressed in mesenchymal cells. since emt in cancer progression recaptures emt in developmental programs, many of the emt-tfs are involved in promoting metastatic events. several signaling pathways (tgf-β, fgf, egf, hgf, wnt/beta-catenin and notch) and hypoxia may induce emt. in particular, ras-mapk has been shown to activate snail and slug. slug triggers the steps of desmosomal disruption, cell spreading, and partial separation at cell–cell borders, which comprise the first and necessary phase of the emt process. on the other hand, slug cannot trigger the second phase, which includes the induction of cell motility, repression of the cytokeratin expression, and activation of vimentin expression. snail and slug are known to regulate the expression of p63 isoforms, another transcription factor that is required for proper development of epithelial structures. the altered expression of p63 isoforms reduced cell–cell adhesion and increased the migratory properties of cancer cells. the p63 factor is involved in inhibiting emt and reduction of certain p63 isoforms may be important in the development of epithelial cancers. some of them are known to regulate the expression of cytokeratins. the phosphatidylinositol 3' kinase (pi3k)/akt axis, hedgehog signaling pathway, nuclear factor-kappab and activating transcription factor 2 have also been implicated to be involved in emt. wnt signaling pathway regulates emt in gastrulation, cardiac valve formation and cancer. activation of wnt pathway in breast cancer cells induces the emt regulator snail and upregulates the mesenchymal marker, vimentin. also, active wnt/beta-catenin pathway correlates with poor prognosis in breast cancer patients in the clinic. similarly, tgf-β activates the expression of snail and zeb to regulate emt in heart development, palatogenesis, and cancer. the breast cancer bone metastasis has activated tgf-β signaling, which contributes to the formation of these lesions. however, on the other hand, p53, a well-known tumor suppressor, represses emt by activating the expression of various micrornas – mir-200 and mir-34 that inhibit the production of protein zeb and snail, and thus maintain the epithelial phenotype. in development and wound healing after the initial stage of embryogenesis, the implantation of the embryo and the initiation of placenta formation are associated with emt. the trophoectoderm cells undergo emt to facilitate the invasion of endometrium and appropriate placenta placement, thus enabling nutrient and gas exchange to the embryo. later in embryogenesis, during gastrulation, emt allows the cells to ingress in a specific area of the embryo – the primitive streak in amniotes, and the ventral furrow in drosophila. the cells in this tissue express e-cadherin and apical-basal polarity. since gastrulation is a very rapid process, e-cadherin is repressed transcriptionally by twist and snai1 (commonly called snail), and at the protein level by p38 interacting protein. the primitive streak, through invagination, further generates mesoendoderm, which separates to form a mesoderm and an endoderm, again through emt. mesenchymal cells from the primitive streak participate also in the formation of many epithelial mesodermal organs, such as notochord as well as somites, through the reverse of emt, i.e. mesenchymal–epithelial transition. amphioxus forms an epithelial neural tube and dorsal notochord but does not have the emt potential of the primitive streak. in higher chordates, the mesenchyme originates out of the primitive streak migrates anteriorly to form the somites and participate with neural crest mesenchyme in formation of the heart mesoderm. in vertebrates, epithelium and mesenchyme are the basic tissue phenotypes. during embryonic development, migratory neural crest cells are generated by emt involving the epithelial cells of the neuroectoderm. as a result, these cells dissociate from neural folds, gain motility, and disseminate to various parts of the embryo, where they differentiate to many other cell types. also, craniofacial crest mesenchyme that forms the connective tissue forming the head and face, is formed by neural tube epithelium by emt. emt takes place during the construction of the vertebral column out of the extracellular matrix, which is to be synthesized by fibroblasts and osteoblasts that encircle the neural tube. the major source of these cells are sclerotome and somite mesenchyme as well as primitive streak. mesenchymal morphology allows the cells to travel to specific targets in the embryo, where they differentiate and/or induce differentiation of other cells. during wound healing, keratinocytes at the border of the wound undergo emt and undergo re-epithelialization or met when the wound is closed. snail2 expression at the migratory front influences this state, as its overexpression accelerates wound healing. similarly, in each menstrual cycle, the ovarian surface epithelium undergoes emt during post-ovulatory wound healing. in cancer progression and metastasis initiation of metastasis requires invasion, which is enabled by emt. carcinoma cells in a primary tumor lose cell-cell adhesion mediated by e-cadherin repression and break through the basement membrane with increased invasive properties, and enter the bloodstream through intravasation. later, when these circulating tumor cells (ctcs) exit the bloodstream to form micro-metastases, they undergo met for clonal outgrowth at these metastatic sites. thus, emt and met form the initiation and completion of the invasion-metastasis cascade. at this new metastatic site, the tumor may undergo other processes to optimize growth. for example, emt has been associated with pd-l1 expression, particularly in lung cancer. increased levels of pd-l1 suppresses the immune system which allows the cancer to spread more easily. emt confers resistance to oncogene-induced premature senescence. twist1 and twist2, as well as zeb1 protects human cells and mouse embryonic fibroblasts from senescence. similarly, tgf-β can promote tumor invasion and evasion of immune surveillance at advanced stages. when tgf-β acts on activated ras-expressing mammary epithelial cells, emt is favored and apoptosis is inhibited. this effect can be reversed by inducers of epithelial differentiation, such as gata-3. emt has been shown to be induced by androgen deprivation therapy in metastatic prostate cancer. activation of emt programs via inhibition of the androgen axis provides a mechanism by which tumor cells can adapt to promote disease recurrence and progression. brachyury, axl, mek, and aurora kinase a are molecular drivers of these programs, and inhibitors are currently in clinical trials to determine therapeutic applications. oncogenic pkc-iota can promote melanoma cell invasion by activating vimentin during emt. pkc-iota inhibition or knockdown resulted an increase e-cadherin and rhoa levels while decreasing total vimentin, phosphorylated vimentin (s39) and par6 in metastatic melanoma cells. these results suggested that pkc-ι is involved in signaling pathways which upregulate emt in melanoma. emt has been indicated to be involved in acquiring drug resistance. gain of emt markers was found to be associated with the resistance of ovarian carcinoma epithelial cell lines to paclitaxel. similarly, snail also confers resistance to paclitaxel, adriamycin and radiotherapy by inhibiting p53-mediated apoptosis. furthermore, inflammation, that has been associated with the progression of cancer and fibrosis, was recently shown to be related to cancer through inflammation-induced emt. consequently, emt enables cells to gain a migratory phenotype, as well as induce multiple immunosuppression, drug resistance, evasion of apoptosis mechanisms. some evidence suggests that cells that undergo emt gain stem cell-like properties, thus giving rise to cancer stem cells (cscs). upon transfection by activated ras, a subpopulation of cells exhibiting the putative stem cell markers cd44high/cd24low increases with the concomitant induction of emt. also, zeb1 is capable of conferring stem cell-like properties, thus strengthening the relationship between emt and stemness. thus, emt may present increased danger to cancer patients, as emt not only enables the carcinoma cells to enter the bloodstream, but also endows them with properties of stemness which increases tumorigenic and proliferative potential. however, recent studies have further shifted the primary effects of emt away from invasion and metastasis, toward resistance to chemotherapeutic agents. research on breast cancer and pancreatic cancer both demonstrated no difference in cells' metastatic potential upon acquisition of emt. these are in agreement with another study showing that the emt transcription factor twist actually requires intact adherens junctions in order to mediate local invasion in breast cancer. the effects of emt and its relationship to invasion and metastasis may therefore be highly context specific. in urothelial carcinoma cell lines overexpression of hdac5 inhibits long-term proliferation but can promote epithelial-to-mesenchymal transition (emt). platelets in cancer emt cancer cells enter the bloodstream after undergoing emt induced by tgf-β released from platelets. once in the bloodstream, metastatic cancer cells recruit platelets for use as a physical barrier that helps protect these cells from elimination by immune cells. the metastatic cancer cell can use the attached platelets to adhere to p-selectin expressed by activated endothelial cells lining the blood vessel walls. following adhesion to the endothelium, the metastatic cancer cell exits the bloodstream at the secondary site to begin formation of a new tumor. platelets in the blood have the ability to initiate the induction of emt in cancer cells. when platelets are recruited to a site in the blood vessel they can release a variety of growth factors (pdgf, vegf, angiopoietin-1) and cytokines including the emt inducer tgf-β. the release of tgf-β by platelets in blood vessels near primary tumors enhances invasiveness and promotes metastasis of cancer cells in the tumor. studies looking at defective platelets and reduced platelet counts in mouse models have shown that impaired platelet function is associated with decreased metastatic formation. in humans, platelet counts and thrombocytosis within the upper end of the normal range have been associated with advanced, often metastatic, stage cancer in cervical cancer, ovarian cancer, gastric cancer, and esophageal cancer. although a great deal of research has been applied to studying interactions between tumor cells and platelets, a cancer therapy targeting this interaction has not yet been established. this may be in part due to the redundancy of prothrombotic